Genes included in both tissue and cfDNA sequencing included multiple known to be important and potentially actionable in gastric cancer including ERBB2 (10), CTNNB1 (24), EGFR (22), MET (7), and KRAS (25). This evidence concerns the gene MET and gastric cancer.